Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat

被引:92
作者
Manusama, ER
Nooijen, PTGA
Stavast, J
Durante, NMC
Marquet, RL
Eggermont, AMM
机构
[1] UNIV ROTTERDAM HOSP,DR DANIEL DENHOED CANC CTR,DEPT SURG,ROTTERDAM,NETHERLANDS
[2] UNIV NIJMEGEN,DEPT PATHOL,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1002/bjs.1800830438
中图分类号
R61 [外科手术学];
学科分类号
摘要
The efficacy of isolated limb perfusion (ILP) for 'in-transit' metastases from malignant melanoma and irresectable soft tissue sarcoma has been improved considerably by the addition of tumour necrosis factor (TNF) alpha. A rat sarcoma tumour model was, therefore, developed to evaluate the effects of TNF-alpha, melphalan and the combination of these drugs in the treatment of sarcoma. In BN rats bearing the non-immunogenic BN 175 sarcoma ILPs were performed with perfusate only, TNF-alpha, melphalan alone, or in combination when tumours had grown to approximately 1.5 cm in diameter. All rats treated with sham perfusion or perfusion with 50 mu g TNF-alpha showed progressive disease. After perfusion with 40 mu g melphalan no change in tumour diameter was observed in any rats at 4 days. After a combined perfusion with 40 mu g melphalan and 50 mu g TNF-alpha complete remission was noted in 12 of 16 rats. This synergistic effect in vivo between relatively ineffective doses of TNF-alpha and melphalan was not observed in vitro.
引用
收藏
页码:551 / 555
页数:5
相关论文
共 34 条
[1]  
ALATTIYAH R, 1992, CLIN EXP IMMUNOL, V88, P537
[2]  
ASHER A, 1987, J IMMUNOL, V138, P963
[3]  
ASHER AL, 1989, CANCER IMMUNOL IMMUN, V28, P153
[4]  
BENCKHUIJSEN C, 1988, EUR J SURG ONCOL, V14, P157
[5]   HIGH-FLOW ISOLATION PERFUSION OF THE RAT HINDLIMB INVIVO [J].
BENCKHUYSEN, C ;
VANDIJK, WJ ;
VANTHOFF, SC .
JOURNAL OF SURGICAL ONCOLOGY, 1982, 21 (04) :249-257
[6]  
BLICK M, 1987, CANCER RES, V47, P2986
[7]   MULTIPLE FACETS OF INDUCTION OF TUMOR NECROSIS [J].
BLOKSMA, N ;
VANDEWIEL, PA ;
KUPER, CF ;
HOFHUIS, FMA .
ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1988, 139 (03) :294-299
[8]   CLINICAL-PHARMACOLOGY OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR IN PATIENTS WITH ADVANCED CANCER [J].
CHAPMAN, PB ;
LESTER, TJ ;
CASPER, ES ;
GABRILOVE, JL ;
WONG, GY ;
KEMPIN, SJ ;
GOLD, PJ ;
WELT, S ;
WARREN, RS ;
STARNES, HF ;
SHERWIN, SA ;
OLD, LJ ;
OETTGEN, HF .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1942-1951
[9]   CHEMOTHERAPY OF CANCER - REGIONAL PERFUSION UTILIZING AN EXTRACORPOREAL CIRCUIT [J].
CREECH, O ;
KREMENTZ, ET ;
RYAN, RF ;
WINBLAD, JN .
ANNALS OF SURGERY, 1958, 148 (04) :616-632
[10]  
Eggermont A, 1994, EUR J SURG ONCOL, V20, P403